Blue Chip Partners, Inc. Eli Lilly & CO Transaction History

Blue Chip Partners, Inc.

$1.15 Billion
Q3 2024

A detailed history of Blue Chip Partners, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Blue Chip Partners, Inc. holds 15,281 shares of LLY stock, worth $11.9 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

15,281

Previous 14,909 2.5%

Holding current value

$11.9 Million

Previous $13.5 Million 0.3%

% of portfolio

1.18%

Previous 1.25%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$772.14 - $960.02 $287,236 - $357,127	372 Added 2.5%	15,281 $13.5 Million
Q2 2024 Jul 29, 2024	BUY	$724.87 - $909.04 $808,230 - $1.01 Million	1,115 Added 8.08%	14,909 $13.5 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $7.11 Million - $9.51 Million	12,002 Added 669.75%	13,794 $10.7 Million
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $1,575 - $1,857	3 Added 0.17%	1,792 $1.04 Million
Q3 2023 Oct 30, 2023	SELL	$434.7 - $599.3 $6,085 - $8,390	-14 Reduced 0.78%	1,789 $960,000
Q2 2023 Aug 02, 2023	BUY	$350.74 - $468.98 $13,328 - $17,821	38 Added 2.15%	1,803 $845,000
Q1 2023 May 01, 2023	SELL	$310.63 - $364.82 $8,076 - $9,485	-26 Reduced 1.45%	1,765 $606,000
Q4 2022 Feb 01, 2023	SELL	$321.55 - $374.67 $11,897 - $13,862	-37 Reduced 2.02%	1,791 $655,000
Q3 2022 Oct 27, 2022	BUY	$296.48 - $337.87 $103,768 - $118,254	350 Added 23.68%	1,828 $591,000
Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $3,623 - $4,254	13 Added 0.89%	1,478 $479,000
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $704 - $874	3 Added 0.21%	1,465 $420,000
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $674 - $837	3 Added 0.21%	1,462 $404,000
Q3 2021 Nov 02, 2021	BUY	$221.6 - $272.71 $20,608 - $25,362	93 Added 6.81%	1,459 $337,000
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $541 - $700	3 Added 0.22%	1,366 $314,000
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $657 - $850	4 Added 0.29%	1,363 $255,000
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $15,263 - $20,197	-117 Reduced 7.93%	1,359 $230,000
Q3 2020 Oct 27, 2020	SELL	$146.22 - $169.13 $5,556 - $6,426	-38 Reduced 2.51%	1,476 $218,000
Q2 2020 Jul 30, 2020	BUY	$136.42 - $164.18 $545 - $656	4 Added 0.26%	1,514 $249,000
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $125,240 - $155,012	-1,052 Reduced 41.06%	1,510 $209,000
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $53,566 - $66,347	-501 Reduced 16.36%	2,562 $337,000
Q3 2019 Oct 29, 2019	BUY	$106.79 - $116.16 $62,472 - $67,953	585 Added 23.61%	3,063 $342,000
Q2 2019 Jul 31, 2019	BUY	$110.79 - $129.32 $1,218 - $1,422	11 Added 0.45%	2,478 $275,000
Q1 2019 Apr 23, 2019	BUY	$111.31 - $131.02 $1,447 - $1,703	13 Added 0.53%	2,467 $320,000
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $1,270 - $1,423	12 Added 0.49%	2,454 $284,000
Q3 2018 Oct 26, 2018	BUY	$85.86 - $107.31 $85 - $107	1 Added 0.04%	2,442 $262,000
Q2 2018 Jul 25, 2018	SELL	$75.7 - $86.88 $10,749 - $12,336	-142 Reduced 5.5%	2,441 $208,000
Q1 2018 Apr 25, 2018	BUY	$74.21 - $87.6 $191,684 - $226,270	2,583 New	2,583 $200,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Chip Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Chip Partners, Inc. with notifications on news.

Account

Blue Chip Partners, Inc. Eli Lilly & CO Transaction History